Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Lung Neoplasms 18Hematologic Neoplasms 10Prostatic Neoplasms 9Colorectal Neoplasms 9Breast Neoplasms 9Hematopoietic and Lymphatic System Neoplasm 8Carcinoma, Non-Small-Cell Lung 7Anatomic Stage I Breast Cancer AJCC v8 7Pancreatic Neoplasms 6Neoplasm Metastasis 6Uterine Cervical Neoplasms 5Urinary Bladder Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Ovarian Neoplasms 4Neoplasms 4Hematopoietic and Lymphoid System Neoplasm 4Head and Neck Carcinoma 4Breast Carcinoma In Situ 4Triple Negative Breast Neoplasms 3Multiple Myeloma 3Melanoma 3Malignant Solid Neoplasm 3Lymphoma 3Leukemia, Myeloid, Acute 3Carcinoma, Renal Cell 3Stomach Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Papillomavirus Infections 2Mouth Neoplasms 2Head and Neck Neoplasms 2

Interventions

Standard of Care 1Practice Guidelines as Topic 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Clear Cell Adenocarcinoma × Practice Guidelines as Topic × 1 year × Clear all
NCT03422198 2025-12-12

SAVE

University of Utah

Phase 3 Recruiting
188 enrolled 15 charts
GynecologicSarcoma

Endometrial Clear Cell Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡